Elevara Medicines

To add a bio or update company history, please click update information.

News from Elevara Medicines

Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis

22 Oct 2025

Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis

Elevara develops oral therapies for rheumatoid arthritis by targeting synovial fibroblasts rather than the immune system, aiming to improve remission rates in chronic inflammatory disease.

Elevara Medicines

Life Sciences
London, United Kingdom
£50m
elevara.com
Update Information

More venture news

BioOrbit
30 Apr 2026
BioOrbit lands a £9.8m seed round co-led by LocalGlobe and Breega to manufacture pharmaceutical drugs in space
SeedLife Sciences
Lightcast
15 Apr 2026
Lightcast lands £20m in funding led by ARCH Venture Partners to advance single-cell analysis platform
EquityLife Sciences
Helical
14 Apr 2026
Helical raises a £7.5m seed round led by redalpine to build virtual labs for pharma research
SeedLife Sciences

Elevara Medicines

News from Elevara Medicines

Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis

More venture news

BioOrbit lands a £9.8m seed round co-led by LocalGlobe and Breega to manufacture pharmaceutical drugs in space

Lightcast lands £20m in funding led by ARCH Venture Partners to advance single-cell analysis platform

Helical raises a £7.5m seed round led by redalpine to build virtual labs for pharma research